Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 59 (3) , 349-362
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01 CA214557, U01 EB028145)
- National Institute of Biomedical Imaging and Bioengineering (R01 CA214557, U01 EB028145)
- National Institutes of Health (R01 CA214557, U01 EB028145)
This publication has 69 references indexed in Scilit:
- Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boostRadiation Oncology, 2013
- Radiation necrosis following treatment of high grade glioma—a review of the literature and current understandingActa Neurochirurgica, 2011
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- In Vivo Proton MR Spectroscopy Evaluation of Pyogenic Brain Abscesses: A Report of 194 CasesAmerican Journal of Neuroradiology, 2009
- Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32‐channel phased‐array coilMagnetic Resonance in Medicine, 2008
- Comments and controversies: Magnetic resonance spectroscopy and gliomasCancer Imaging, 2006
- Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopyNeurosurgical Review, 2005
- MRI in treatment of adult gliomasThe Lancet Oncology, 2005
- Characterization of macromolecule resonances in the 1H NMR spectrum of rat brainMagnetic Resonance in Medicine, 1993
- Spatial mapping of the chemical shift in NMRMagnetic Resonance in Medicine, 1984